Hims & Hers (HIMS) CMO Patrick Harrison Receives 260 RSU Award

What Happened

• Patrick Harrison, Chief Medical Officer of Hims & Hers (HIMS), was granted 260 Restricted Stock Units (RSUs) on 2026-08-12. The Form 4 reports an acquisition (award) of 260 RSUs at an acquisition price of $0.00. Using the grant price of $30.40, the award equates to roughly $7.9K in value (the grant replaced $7,912 of cash fees).

Key Details

• Transaction date: 2026-08-12; Form 4 filed: 2026-08-14 (appears timely).
• Transaction type/code: A — Award/Grant of RSUs (derivative).
• Grant price used for calculation: $30.40; reported RSUs: 260; implied value ≈ $7,904–$7,912 (rounding).
• Acquisition price: $0.00 (typical for RSU grants; taxable/stock delivery event occurs at vesting).
• Vesting: RSUs will vest in full on the Company’s next quarterly vesting date (per filing).
• Shares owned after transaction: Not specified on the provided summary of the Form 4.
• Footnote highlights: RSUs represent a contingent right to receive one share of Class A Common Stock per RSU and were issued pursuant to the issuer’s Director Compensation Policy in lieu of the Q2 2026 director retainer fee.

Context

• This was a compensation award (RSUs) rather than an open‑market purchase or sale. Such awards are routine forms of pay and do not by themselves indicate insider buying or selling sentiment. As a derivative grant, the RSUs convert to actual shares only upon vesting.